Zentiva S A : SCD_Zentiva_Annual Report 2023-EN
Annual Report of the Board of Directors for the financial year 2023 Reporting date: 31 December 2023 ...
Stay updated with breaking news from Advent Funds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Annual Report of the Board of Directors for the financial year 2023 Reporting date: 31 December 2023 ...
Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO
The approval is for the acquisition of up to 76.1 percent stake in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.
Proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies, after meeting of Cabinet Committee on Economic Affairs
The Indian government has approved a foreign direct investment (FDI) proposal worth Rs. 9,589 crore in Suven Pharmaceuticals Limited. Private equity firm Advent International will acquire a 50.1% stake in the company for Rs. 6,313 crore, with plans to launch an open offer for an additional 26%.